![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 47/68 | (2017.01) |
C07D 519/00 | (2006.01) | ||
A61P 39/00 | (2006.01) | ||
A61P 35/00 | (2006.01) |
(11) | Number of the document | 3470086 |
(13) | Kind of document | T |
(96) | European patent application number | 18187765.5 |
Date of filing the European patent application | 2013-10-11 | |
(97) | Date of publication of the European application | 2019-04-17 |
(45) | Date of publication and mention of the grant of the patent | 2020-11-25 |
(46) | Date of publication of the claims translation | 2021-02-25 |
(30) | Number | Date | Country code |
201261712924 P | 2012-10-12 | US |
(72) |
Howard, Philip Wilson, GB
|
(73) |
MEDIMMUNE LIMITED,
Milstein Building Granta Park, Cambridge CB21 6GH,
GB
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Pirolobenzodiazepinai ir jų konjugatai |
PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF |
Payment date | Validity (years) | Amount | |
2025-09-23 | 13 | 289.00 EUR |
2026-10-11 |